GO:0018958 | phenol-containing compound metabolic process | 4.62% (3/65) | 7.32 | 1e-06 | 7.8e-05 |
GO:0080032 | methyl jasmonate esterase activity | 4.62% (3/65) | 7.41 | 1e-06 | 8.1e-05 |
GO:0080031 | methyl salicylate esterase activity | 4.62% (3/65) | 7.41 | 1e-06 | 8.1e-05 |
GO:0009696 | salicylic acid metabolic process | 4.62% (3/65) | 7.41 | 1e-06 | 8.1e-05 |
GO:0080030 | methyl indole-3-acetate esterase activity | 4.62% (3/65) | 7.41 | 1e-06 | 8.1e-05 |
GO:0009694 | jasmonic acid metabolic process | 4.62% (3/65) | 7.05 | 2e-06 | 0.000113 |
GO:0042537 | benzene-containing compound metabolic process | 4.62% (3/65) | 6.77 | 3e-06 | 0.000176 |
GO:0001676 | long-chain fatty acid metabolic process | 4.62% (3/65) | 6.67 | 4e-06 | 0.000189 |
GO:0006631 | fatty acid metabolic process | 6.15% (4/65) | 4.4 | 4.2e-05 | 0.001791 |
GO:0044281 | small molecule metabolic process | 12.31% (8/65) | 2.37 | 0.000153 | 0.005835 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 3.08% (2/65) | 5.97 | 0.000493 | 0.017067 |
GO:0052689 | carboxylic ester hydrolase activity | 4.62% (3/65) | 4.17 | 0.000647 | 0.017602 |
GO:0006220 | pyrimidine nucleotide metabolic process | 3.08% (2/65) | 5.37 | 0.001108 | 0.018359 |
GO:0032205 | negative regulation of telomere maintenance | 1.54% (1/65) | 10.0 | 0.000973 | 0.018537 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 1.54% (1/65) | 10.0 | 0.000973 | 0.018537 |
GO:1904357 | negative regulation of telomere maintenance via telomere lengthening | 1.54% (1/65) | 10.0 | 0.000973 | 0.018537 |
GO:0046112 | nucleobase biosynthetic process | 3.08% (2/65) | 5.58 | 0.000838 | 0.018772 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 3.08% (2/65) | 5.62 | 0.000791 | 0.018841 |
GO:0008835 | diaminohydroxyphosphoribosylaminopyrimidine deaminase activity | 1.54% (1/65) | 9.72 | 0.001189 | 0.018878 |
GO:0006206 | pyrimidine nucleobase metabolic process | 3.08% (2/65) | 5.77 | 0.000645 | 0.018893 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 3.08% (2/65) | 5.38 | 0.001103 | 0.019109 |
GO:0008974 | phosphoribulokinase activity | 1.54% (1/65) | 9.85 | 0.001081 | 0.019615 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 3.08% (2/65) | 5.62 | 0.000787 | 0.019991 |
GO:0032787 | monocarboxylic acid metabolic process | 6.15% (4/65) | 3.37 | 0.000634 | 0.020136 |
GO:0072374 | carotene epsilon hydroxylase activity | 1.54% (1/65) | 9.37 | 0.001513 | 0.020591 |
GO:0009974 | zeinoxanthin epsilon hydroxylase activity | 1.54% (1/65) | 9.37 | 0.001513 | 0.020591 |
GO:0009112 | nucleobase metabolic process | 3.08% (2/65) | 5.21 | 0.001377 | 0.020987 |
GO:0044255 | cellular lipid metabolic process | 7.69% (5/65) | 2.6 | 0.001442 | 0.021134 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 3.08% (2/65) | 5.0 | 0.001833 | 0.024079 |
GO:1901615 | organic hydroxy compound metabolic process | 4.62% (3/65) | 3.63 | 0.001899 | 0.02412 |
GO:0072527 | pyrimidine-containing compound metabolic process | 3.08% (2/65) | 4.88 | 0.002164 | 0.026601 |
GO:0140678 | molecular function inhibitor activity | 3.08% (2/65) | 4.43 | 0.003981 | 0.045963 |
GO:0004857 | enzyme inhibitor activity | 3.08% (2/65) | 4.44 | 0.003918 | 0.046651 |